Our Biotechnology & Life Sciences practice has vast experience in a wide range of patent issues, and offers a full range of consulting services relating to biotech-specific IP and regulatory issues. 

We have handled numerous patent litigations involving original antibody drugs, biosimilars and vaccines, as well as biologics-related trade secret cases.  Our prosecution work has covered areas such as recombinant protein therapeutics, gene/cell therapies and bioinformatics-based diagnosis methods.  We also provide support on the technical aspects of product liability issues, biological drug regulations including pricing and Nagoya Protocol issues.